To include your compound in the COVID-19 Resource Center, submit it here.

Mylovenge: Phase II

Long-term follow-up of Phase II trials of Mylovenge showed that the product gave tumor regression or disease stabilization

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE